4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001231615-25-000004
Director sold 36,694 shares at an average $120.05 ($4,405,216)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
JEFFS ROGER · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-22 | Sale : show line 1 in the form 10b5-1 | −16,694 | $120.08 | $2,004,616 | 150,974 | D |
| 2025-08-26 | Sale : show line 2 in the form 10b5-1 | −20,000 | $120.03 | $2,400,600 | 130,974 | D |
| Open-market sales · 36,694 sh · avg $120.05 · $4,405,216 | ||||||
Loading xslF345X05/ownership.xml…